Skip to content
Back to outputs

Exercise testing in cystic fibrosis: who and why?

Research output: Research - peer-reviewArticle

Standard

Exercise testing in cystic fibrosis: who and why? / Urquhart, D. S.; Saynor, Zoe.

In: Paediatric Respiratory Reviews, 05.12.2017.

Research output: Research - peer-reviewArticle

Harvard

Urquhart, DS & Saynor, Z 2017, 'Exercise testing in cystic fibrosis: who and why?' Paediatric Respiratory Reviews.

APA

Urquhart, D. S., & Saynor, Z. (2017). Exercise testing in cystic fibrosis: who and why? Paediatric Respiratory Reviews.

Vancouver

Urquhart DS, Saynor Z. Exercise testing in cystic fibrosis: who and why? Paediatric Respiratory Reviews. 2017 Dec 5.

Author

Urquhart, D. S. ; Saynor, Zoe. / Exercise testing in cystic fibrosis: who and why?. In: Paediatric Respiratory Reviews. 2017

Bibtex

@article{e9fa4a79a8a74e138fb317534bdd153c,
title = "Exercise testing in cystic fibrosis: who and why?",
abstract = "Annual review exercise testing is recommended by the Cystic Fibrosis (CF) Trust. Testing to date has focused on evaluating aerobic fitness, a key prognostic indicator. Tests available range from simple field tests, to comprehensive evaluations of aerobic exercise (dys)function – cardiopulmonary exercise testing (CPET).‘Field tests’, although easy to perform are limited in the information they provide. Whereas CPET, the ‘gold standard’ measure of aerobic fitness, is recommended as the first choice exercise test by the European CF Society Exercise Working Group. CPET offers a precise cardiovascular, respiratory and metabolic evaluation of exercise capacity, including assessment of mechanism(s) of exercise limitation.",
keywords = "cystic fibrosis, exercise, exercise physiology, cardiopulmonary exercise testing (CPET)",
author = "Urquhart, {D. S.} and Zoe Saynor",
note = "12 months embargo",
year = "2017",
month = "12",
journal = "Paediatric Respiratory Reviews",
issn = "1526-0542",
publisher = "W. B. Saunders Ltd",

}

RIS

TY - JOUR

T1 - Exercise testing in cystic fibrosis: who and why?

AU - Urquhart,D. S.

AU - Saynor,Zoe

N1 - 12 months embargo

PY - 2017/12/5

Y1 - 2017/12/5

N2 - Annual review exercise testing is recommended by the Cystic Fibrosis (CF) Trust. Testing to date has focused on evaluating aerobic fitness, a key prognostic indicator. Tests available range from simple field tests, to comprehensive evaluations of aerobic exercise (dys)function – cardiopulmonary exercise testing (CPET).‘Field tests’, although easy to perform are limited in the information they provide. Whereas CPET, the ‘gold standard’ measure of aerobic fitness, is recommended as the first choice exercise test by the European CF Society Exercise Working Group. CPET offers a precise cardiovascular, respiratory and metabolic evaluation of exercise capacity, including assessment of mechanism(s) of exercise limitation.

AB - Annual review exercise testing is recommended by the Cystic Fibrosis (CF) Trust. Testing to date has focused on evaluating aerobic fitness, a key prognostic indicator. Tests available range from simple field tests, to comprehensive evaluations of aerobic exercise (dys)function – cardiopulmonary exercise testing (CPET).‘Field tests’, although easy to perform are limited in the information they provide. Whereas CPET, the ‘gold standard’ measure of aerobic fitness, is recommended as the first choice exercise test by the European CF Society Exercise Working Group. CPET offers a precise cardiovascular, respiratory and metabolic evaluation of exercise capacity, including assessment of mechanism(s) of exercise limitation.

KW - cystic fibrosis

KW - exercise

KW - exercise physiology

KW - cardiopulmonary exercise testing (CPET)

M3 - Article

JO - Paediatric Respiratory Reviews

T2 - Paediatric Respiratory Reviews

JF - Paediatric Respiratory Reviews

SN - 1526-0542

ER -

ID: 8656346